Does mutated K-RAS oncogene attenuate the effect of Sulindac in colon cancer chemoprevention?

類似資料

• Intermittent dosing with sulindac provides effective colorectal cancer chemoprevention in the azoxymethane-treated mouse model
  著者:: Chandra, Swati, 等
  出版事項: (2017)
• Randomized, Double-blind, Placebo Controlled Trial of Sulindac in Individuals at Risk for Melanoma: Evaluation of Potential Chemopreventive Activity
  著者:: Curiel-Lewandrowski, Clara, 等
  出版事項: (2012)
• Preclinical Evaluation of the Efficacy of α-Difluoromethylornithine and Sulindac Against SARS-CoV-2 Infection
  著者:: Natalia A. Ignatenko, 等
  出版事項: (2025-09-01)
• PRIMARY CHEMOPREVENTION OF FAMILIAL ADENOMATOUS POLYPOSIS WITH SULINDAC
  著者:: Giardiello, Francis M., 等
  出版事項: (2002)
• Sulindac sulfide suppresses oncogenic transformation through let-7b-mediated repression of K-Ras signaling
  著者:: Zhipin Liang, 等
  出版事項: (2025-11-01)